A detailed history of Embree Financial Group transactions in Merck & Co., Inc. stock. As of the latest transaction made, Embree Financial Group holds 4,154 shares of MRK stock, worth $414,859. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,154
Previous 4,239 2.01%
Holding current value
$414,859
Previous $525 Million 10.1%
% of portfolio
0.08%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$111.15 - $128.97 $9,447 - $10,962
-85 Reduced 2.01%
4,154 $472 Million
Q2 2024

Aug 01, 2024

BUY
$123.8 - $132.96 $1,361 - $1,462
11 Added 0.26%
4,239 $525 Million
Q1 2024

May 03, 2024

SELL
$113.24 - $131.95 $33,292 - $38,793
-294 Reduced 6.5%
4,228 $558 Million
Q4 2023

Apr 30, 2024

BUY
$100.18 - $109.02 $453,013 - $492,988
4,522 New
4,522 $493 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Embree Financial Group Portfolio

Follow Embree Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Embree Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Embree Financial Group with notifications on news.